<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Woods, R.</title>
    <link>http://repub.eur.nl/res/aut/684/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis (Article)</title>
      <link>http://repub.eur.nl/res/pub/10301/</link>
      <pubDate>2004-01-01T00:00:00Z</pubDate>
      <description>For effective clinical management of cystic fibrosis (CF) lung disease it
      is important to closely monitor the start and progression of lung damage.
      The aim of this study was to investigate the ability of high-resolution
      computed tomography (HRCT) scoring systems and pulmonary function tests
      (PFT) to detect changes in lung disease. CF children (n=48) had two HRCT
      scans in combination with two PFT 2 yrs apart. Their scans were scored
      using five scoring systems (Castile, Brody, Helbich, Santamaria and
      Bhalla). "Sensitivity" was defined as the ability to detect disease
      progression. In this group of children, HRCT scores worsened. PFT remained
      unchanged or improved. Of the HRCT parameters, mucous plugging and the
      severity, extent and peripheral extension of bronchiectasis worsened
      significantly. Relationships between changes in HRCT scores and PFT were
      weak. Substantial structural lung damage was evident in some children who
      had normal lung function. These data show that high-resolution computed
      tomography is more sensitive than pulmonary function tests in the
      detection of early and progressive lung disease, and suggest that
      high-resolution computed tomography may be useful in the follow up of
      cystic fibrosis children and as an outcome measure in studies that aim to
      reduce lung damage.</description>
    </item>
  </channel>
</rss>